- Home
- LFWD vs NNVC Comparison
LFWD vs NNVC Comparison
Compare LFWD & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFWD
- NNVC
- Stock Information
- Founded
- LFWD 2001
- NNVC 2005
- Country
- LFWD Israel
- NNVC United States
- Employees
- LFWD N/A
- NNVC N/A
- Industry
- LFWD
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- LFWD
- NNVC Health Care
- Exchange
- LFWD NYSE
- NNVC Nasdaq
- Market Cap
- LFWD 20.0M
- NNVC 17.7M
- IPO Year
- LFWD 2014
- NNVC N/A
- Fundamental
- Price
- LFWD $1.86
- NNVC $1.30
- Analyst Decision
- LFWD Strong Buy
- NNVC Strong Buy
- Analyst Count
- LFWD 1
- NNVC 1
- Target Price
- LFWD $13.00
- NNVC $6.50
- AVG Volume (30 Days)
- LFWD 50.1K
- NNVC 138.9K
- Earning Date
- LFWD 11-12-2024
- NNVC 11-14-2024
- Dividend Yield
- LFWD N/A
- NNVC N/A
- EPS Growth
- LFWD N/A
- NNVC N/A
- EPS
- LFWD N/A
- NNVC N/A
- Revenue
- LFWD $25,002,000.00
- NNVC N/A
- Revenue This Year
- LFWD $124.19
- NNVC N/A
- Revenue Next Year
- LFWD $44.50
- NNVC N/A
- P/E Ratio
- LFWD N/A
- NNVC N/A
- Revenue Growth
- LFWD 173.28
- NNVC N/A
- 52 Week Low
- LFWD $1.70
- NNVC $1.00
- 52 Week High
- LFWD $9.10
- NNVC $3.59
- Technical
- Relative Strength Index (RSI)
- LFWD 33.09
- NNVC 39.95
- Support Level
- LFWD $2.05
- NNVC $1.20
- Resistance Level
- LFWD $2.47
- NNVC $1.39
- Average True Range (ATR)
- LFWD 0.20
- NNVC 0.09
- MACD
- LFWD -0.01
- NNVC -0.01
- Stochastic Oscillator
- LFWD 20.78
- NNVC 21.05
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.